|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn819403408 |
| 003 |
OCoLC |
| 005 |
20231117044758.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
121127s1963 xx o 000 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d OCLCF
|d OCLCQ
|d LEAUB
|d VLY
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780123956224
|q (electronic bk.)
|
| 020 |
|
|
|a 0123956226
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)819403408
|
| 050 |
|
4 |
|a QP601.5
|b .M48 1963
|
| 082 |
0 |
4 |
|a 615.3/5
|2 23
|
| 245 |
0 |
0 |
|a Metabolic inhibitors.
|n Volume 1 :
|b a comprehensive treatise /
|c [edited by] R. Hochster.
|
| 260 |
|
|
|a [Place of publication not identified] :
|b Academic Press,
|c 1963.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Publisher supplied information; title not viewed.
|
| 505 |
8 |
|
|a v. ANALOGUES OF THE POLYPEPTIDE AND PROTEIN HORMONESVI. MODIFIED ENZYMES AS INHIBITORS; VII. MISCELLANEOUS DI- AND TRIPEPTIDE INHIBITORS; VIII. CONCLUDING REMARKS; REFERENCES; CHAPTER 3. Hexose and Pentose Analogues; I. INTRODUCTION; II. HEXOSES; III. PENTOSES; IV. CONCLUSIONS; REFERENCES; CHAPTER 4. Fatty Acids and Their Analogues; I. METABOLIC INHIBITORY EFFECTS OF NORMAL FATTY ACIDS; II. METABOLIC INHIBITORY EFFECTS OF ACYL COENZYME A DERIVATIVES; III. FATTY ACID ANALOGUES; REFERENCES; CHAPTER 5. Phospholipids; I. PHOSPHOLIPID CATABOLISM; II. PHOSPHOLIPID SYNTHESIS
|
| 505 |
8 |
|
|a III. ION TRANSPORT AND PHOSPHOLIPID METABOLISMIV. ALTERNATIVE PATHWAY FOR LECITHIN SYNTHESIS; TRANSMETHYLATION INVOLVING GLYCEROPHOSPHATIDES; V. CONCLUSIONS; REFERENCES; CHAPTER 6. Purine Analogues; I. INTRODUCTION; II. CELLULAR MULTIPLICATION; III. EFFECTS IN THE WHOLE ORGANISM; IV. EFFECTS ON FUNCTION; V. BIOCHEMICAL EFFECTS; VI. CONCLUSION; REFERENCES; CHAPTER 7. Pyrimidine Analogues; I. INTRODUCTION; II. BIOSYNTHESIS AND METABOLIC FUNCTIONS OF PYRIMIDINE NUCLEOTIDES; III. PYRIMIDINE ANALOGUES; IV. OTHER INHIBITORS OF PYRIMIDINE NUCLEOTIDE BIOSYNTHESIS; ACKNOWLEDGMENT; REFERENCES
|
| 505 |
8 |
|
|a XI. PYRIDOXAL-5-PHOSPHATE (CODECARBOXYLASE), VITAMIN B6, B6-DEFICIENCY, B6-ANTAGONISTS (cf. Section XIII)XII. ACTIVATORS, STABILIZERS, AND COFACTORS OTHER THAN B6-PO4; XIII. CARBONYL REAGENTS AND INHIBITORS ACTING ON COENZYME OTHER THAN CYANIDE, SUBSTRATE ANALOGUES, AND PYRIDOXINE ANTAGONISTS; XIV. HORMONES; XV. MISCELLANEOUS; XVI. SUBSTRATE ANALOGUES; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 10. Inhibitors, Antagonists, and Inactivators in the Etiology of Diabetes Mellitus in Man; I. INTRODUCTION; II. INSULINOGENESIS; III. RELEASE OF INSULIN; IV. IMPAIRMENT OF INSULINOGENESIS
|
| 650 |
|
0 |
|a Enzyme inhibitors.
|
| 650 |
|
6 |
|a Antienzymes.
|0 (CaQQLa)201-0014725
|
| 650 |
|
7 |
|a Enzyme inhibitors
|2 fast
|0 (OCoLC)fst00913597
|
| 700 |
1 |
|
|a Hochster, R. M.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123956224
|z Texto completo
|
